<DOC>
	<DOCNO>NCT00430924</DOCNO>
	<brief_summary>The purpose study examine whether inhibition aldosterone result low excretion protein via urine . The hypothesis loss protein lower , progression renal disease slow otherwise expect .</brief_summary>
	<brief_title>Inhibition Aldosterone Patients With Chronic Renal Disease</brief_title>
	<detailed_description>Patients chronic renal disease likely progress end stage renal disease need renal replacement therapy . It accept proteinuria surrogate measurement progression . If proteinuria lower hope prolong patient pre-dialysis phase . Our theory aldosterone inhibition lead . For period 8 week patient randomize either aldosterone receptor inhibition drug eplerenone control without . Blood pressure keep level use drug .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>Proteinuria &gt; 500 mg/24 hour Hypertension antihypertensive treatment Diabetic nephropathy GFR &lt; 20 ml/min Ppotassium 3,5 mmol/l 5,0 mmol/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Kidney Failure , Chronic</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Aldosterone</keyword>
	<keyword>Renin-Angiotensin System</keyword>
</DOC>